Corange
Executive Summary
Deputy Chairman Karl Pohl named interim chairman of the Boehringer-Mannheim/DePuy holding company. Board announces March 11 that it "no longer recognizes Mr. Curt Engelhorn" as chairman. "The board emphasizes also that it retains its confidence in the local management of Boehringer Mannheim" and "fully supports" CEO Max Link "and his proposals." Link joined Corange in May and has orchestrated large investments by the company in Protein Design Labs and CellPro